Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
Donor gene clue to kidney transplant rejection

Donor gene clue to kidney transplant rejection

Clinical trial to study immunosuppressant tacrolimus against generics

Clinical trial to study immunosuppressant tacrolimus against generics

Bone marrow transplants hold promise for sickle cell patients

Bone marrow transplants hold promise for sickle cell patients

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Warning over sirolimus in HCV-positive liver transplantation

Warning over sirolimus in HCV-positive liver transplantation

Sirolimus has anti-skin cancer effect in kidney transplant patients

Sirolimus has anti-skin cancer effect in kidney transplant patients

Pneumococcal revaccination needed in kidney transplant patients

Pneumococcal revaccination needed in kidney transplant patients

Maraviroc reduces incidence of GvHD in blood cancer patients after bone marrow transplantation

Maraviroc reduces incidence of GvHD in blood cancer patients after bone marrow transplantation

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

Enrolment complete in Veloxis LCP-Tacro Phase III study in de novo kidney transplant patients

Enrolment complete in Veloxis LCP-Tacro Phase III study in de novo kidney transplant patients

Juvenile arthritis affected kids are at a high risk of cancer: Study

Juvenile arthritis affected kids are at a high risk of cancer: Study

Abbott's Tacrolimus assay provides consistent medication monitoring for organ transplant patients

Abbott's Tacrolimus assay provides consistent medication monitoring for organ transplant patients

Dr. Reddy’s third quarter revenues increase 46% to $522 million

Dr. Reddy’s third quarter revenues increase 46% to $522 million

Veloxis commences LCP-Tacro Phase IIIb study in kidney transplant patients

Veloxis commences LCP-Tacro Phase IIIb study in kidney transplant patients

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

Maraviroc reduces incidence of GvHD in blood cancer patients after ASCT

Maraviroc reduces incidence of GvHD in blood cancer patients after ASCT

Treatments for lymphoma with no side effects

Treatments for lymphoma with no side effects

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Geron announces data from ongoing GRNOPC1 Phase 1 trial on spinal cord injury

Geron announces data from ongoing GRNOPC1 Phase 1 trial on spinal cord injury

New technique stimulates stem cells after liver transplant to prevent rejection

New technique stimulates stem cells after liver transplant to prevent rejection